杭州联川生物技术股份有限公司, founded in 2006, is a dynamic player in the Biotechnology and Health Care industries. The company operates under the slogan: “Empowering life science and medical research through advanced genetic testing medical devices and innovative research solutions.” Specializing in bioinformatics and sequencing, Lianchuan Bio provides cutting-edge research services and solutions to its life science and medical research clientele.
What sets the company apart is its adept transition into the clinical application space, marked by the independent development of innovative genetic testing medical devices. This strategic advancement aligns well with the growing demand for precision medicine solutions, underscoring their commitment to leveraging foundational gene technology expertise.
The company secured a CNY100.00M Series C investment on 17 October 2021, highlighting investor confidence in its capabilities and potential for growth in a competitive market.
Biomatcell AB
